Public Affairs Committee

Purpose:

To advocate for the MedTech industry with relevant stakeholders across the key areas in healthcare policy, reimbursement, regulatory, industry development and sustainability. The Committee provides oversight of Reimbursement, Industry Policy subcommittees for coordinated and aligned strategies and communications.

Objectives:

  1. Develop and implement an advocacy program which includes active stakeholder engagement to promote the policy positions on strategic issues identified by its subcommittees.
  2. Oversee implementation and content of the Digital Advocacy Platform.

 

MTAA Secretary: Edward Strong, Communications and Public Affairs Coordinator

MTAA Committee Lead: Matthew Versi, Public Affairs and Advocacy Manager

Member

Company

Susan Martin (Chair and Board Director)

Johnson & Johnson Medical

Chris Czelecky (Board Director)

Olympus

Daniel Kildea (Chair of Industry Policy Committee)

Johnson & Johnson Medical

Mahesh Datar (Chair of Regulatory Committee)

Medtronic

Michael Simmonds (Chair of Reimbursement Committee)

Boston Scientific

Beth Roberts

KLS Martin Australia

Paul Davies

Abbott

Mark Taffa

Horten Medical

Liz Carnabuci

Medtronic

Robyn Chu

Alcon

Michael Reynolds

Biotronik

Fraser Cleave

LifeHealthcare

Clinton Lubcke

Baxter Healthcare

Polo Guilbert-Wright

Edwards Lifesciences

Julia Wenner

Terumo Blood and Cell Technologies

Justin Keenan

Cook Medical

Alex Best

Johnson & Johnson Medical

James Doyle

Stryker

 

Meeting dates for 2021:

  • Tuesday, 2 February
  • Tuesday, 30 March
  • Wednesday, 2 June
  • Tuesday, 10 August
  • Tuesday, 5 October
  • Tuesday, 16 November